Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients

Clinical trial NCT00280917 · COMPLETED

Trial details

NCT number: NCT00280917
Sponsor: Can-Fite BioPharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2006-06-01
Primary completion: 2007-04-01
Enrollment: 254

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.